Exchange Traded Concepts’s Sarepta Therapeutics SRPT Stock Holding History

Exchange Traded Concepts’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,644	Closed	-$131K	–	1538
2025 Q2	$131K	Buy	7,644 +144	+2%	+$6.14K	﹤0.01%	1234
2025 Q1	$479K	Buy	+7,500	New	+$790K	0.01%	791
2024 Q3	–	Sell	-61	Closed	-$9.64K	–	1424
2024 Q2	$9.64K	Buy	61 +15	+33%	+$1.93K	﹤0.01%	1085
2024 Q1	$5.96K	Buy	+46	New	+$5.63K	﹤0.01%	1151
2023 Q1	–	Sell	-685	Closed	-$88.8K	–	1266
2022 Q4	$88.8K	Buy	685 +97	+16%	+$11.2K	﹤0.01%	773
2022 Q3	$65K	Sell	588 -45	-7%	-$4.54K	﹤0.01%	801
2022 Q2	$47K	Buy	633 +416	+192%	+$30.6K	﹤0.01%	920
2022 Q1	$17K	Buy	+217	New	+$16.6K	﹤0.01%	1048
2021 Q1	–	Sell	-527	Closed	-$90K	–	1153
2020 Q4	$90K	Buy	+527	New	+$78.1K	﹤0.01%	679

Other funds holding SRPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Exchange Traded Concepts's SRPT Position: Q3 2025 in Review

Exchange Traded Concepts sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 7,644 shares — an estimated $131K sold.

Exchange Traded Concepts first reported a position in SRPT in Q4 2020 and held it in 9 quarters. The position peaked at $479K in Q1 2025. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

Exchange Traded Concepts reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
Exchange Traded Concepts sold 7,644 Sarepta Therapeutics shares in Q3 2025, an estimated $131K.
Exchange Traded Concepts first reported a position in Sarepta Therapeutics in Q4 2020 and held it in 9 quarters.
Exchange Traded Concepts's Sarepta Therapeutics position peaked at $479K in Q1 2025.
319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Exchange Traded Concepts's 13F filing for Q3 2025, filed 14 Oct 2025.